Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of series A Convertible Preferred Stock Closed: US$21M raised · RBW Capital Partners LLC Dealers: RBW Capital Partners LLC (lead) Use of proceeds: Working capital, a portion of the cash component of the proposed DCS acquisition, and general corporate purposes | Apr 20, 2026 |
| Senior secured convertible debenture Announced: US$3M · Dawson James Securities, Inc. +1 Dealers: Dawson James Securities, Inc. (co-lead), RBW Capital Partners LLC (co-lead) Use of proceeds: General working capital and operating expenses | Feb 20, 2025 |
| Business combination proceeds (SPAC trust funds and concurrent PIPE) Closed: US$3.8M raised Use of proceeds: Accelerate development of its pipeline and finance key therapeutic programs to data announcements | Feb 20, 2025 |